Large-scale candidate gene analysis of HDL particle features

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Kaess, Bernhard M ^a,b   Tomaszewski, Maciej ^a   Braund, Peter S ^a   Stark, Klaus ^b   Rafelt, Suzanne ^a   Fischer, Marcus ^b   Hardwick, Robert ^a   Nelson, Christopher P ^a   Debiec, Radoslaw ^a   Huber, Fritz ^c   Kremer, Werner ^c,d   Kalbitzer, Hans Robert ^c,d   Rose, Lynda M ^e   Chasman, Daniel I ^e   Hopewell, Jemma ^f   Clarke, Robert ^f   Burton, Paul R ^a   Tobin, Martin D ^a   Hengstenberg, Christian ^b   Samani, Nilesh J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c LipoFIT Analytic GmbH   (Germany)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; DELTA SARCOGLYCAN; FIBULIN 5; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; COPY NUMBER VARIATION; FAMILY STUDY; FEMALE; GENE FUNCTION; GENE LOCUS; GENETIC ANALYSIS; GENETIC TRAIT; GENOTYPE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; STEROL ANALYSIS; CARDIOVASCULAR DISEASE; FAMILY; GENETIC ASSOCIATION; GENETICS; METHODOLOGY; UNITED KINGDOM;

CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; FAMILY; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GREAT BRITAIN; HUMANS; LIPOPROTEINS, HDL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHENOTYPE;

EID: 79251617578     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014529     Document Type: Article

References (36)

1. Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, et al. (1998) Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 18: 1046-1053.
2. El Harchaoui K, Arsenault BJ, Franssen R, Despres JP, Hovingh GK, et al. (2009) High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med 150: 84-93.
3. Arsenault BJ, Lemieux I, Despres JP, Gagnon P, Wareham NJ, et al. (2009) HDL particle size and the risk of coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study. Atherosclerosis.
4. Superko HR (2009) Advanced lipoprotein testing and subfractionation are clinically useful. Circulation 119: 2383-2395.
5. Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, et al. (2009) Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 119: 931-939.
6. Rosenson RS, Otvos JD, Freedman DS (2002) Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLACI) trial. Am J Cardiol 90: 89-94.
7. de Souza JA, Vindis C, Hansel B, Negre-Salvayre A, Therond P, et al. (2008) Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity. Atherosclerosis 197: 84-94.
8. Mora S (2009) Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use. Circulation 119: 2396-2404.
9. Kaess B, Fischer M, Baessler A, Stark K, Huber F, et al. (2008) The lipoprotein subfraction profile: heritability and identification of quantitative trait loci. J Lipid Res 49: 715-723.
10. O'Connell DL, Heller RF, Roberts DC, Allen JR, Knapp JC, et al. (1988) Twin study of genetic and environmental effects on lipid levels. Genet Epidemiol 5: 323-341.
11. Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, et al. (2009) Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 41: 47-55.
12. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, et al. (2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41: 56-65.
13. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707-713.
14. Tobin MD, Tomaszewski M, Braund PS, Hajat C, Raleigh SM, et al. (2008) Common variants in genes underlying monogenic hypertension and hypotension and blood pressure in the general population. Hypertension 51: 1658-1664.
15. Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, et al. (2008) Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS One 3: e3583.
16. Almasy L, Blangero J (1998) Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62: 1198-1211.
17. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
18. Benjamini Y, Hochberg Y (1995) Controlling the false dicovery rate: a practical and powerful approach to multiple testing. JRSS 57: 289-300.
19. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100: 9440-9445.
20. Chasman DI, Pare G, Mora S, Hopewell JC, Peloso G, et al. (2009) Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet 5: e1000730.
21. Clarke R, Peden JF, Hopewell JC, Kyriakou T, Goel A, et al. (2009) Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 361: 2518-2528.
22. Pietilainen KH, Soderlund S, Rissanen A, Nakanishi S, Jauhiainen M, et al. (2009) HDL subspecies in young adult twins: heritability and impact of overweight. Obesity (Silver Spring) 17: 1208-1214.
23. Otvos JD, Jeyarajah EJ, Bennett DW (1991) Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. Clin Chem 37: 377-386.
24. Rader D (2006) Molecular regulation of HDL metabolism and function: implications for novel therapies. JCI 116: 3090-3100.
25. Coral-Vazquez R, Cohn RD, Moore SA, Hill JA, Weiss RM, et al. (1999) Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell 98: 465-474.
26. Yanagisawa H, Davis EC, Starcher BC, Ouchi T, Yanagisawa M, et al. (2002) Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 415: 168-171.
27. Spencer JA, Hacker SL, Davis EC, Mecham RP, Knutsen RH, et al. (2005) Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration. Proc Natl Acad Sci U S A 102: 2946-2951.
28. Stone EM, Braun TA, Russell SR, Kuehn MH, Lotery AJ, et al. (2004) Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med 351: 346-353.
29. Hu Q, Loeys BL, Coucke PJ, De Paepe A, Mecham RP, et al. (2006) Fibulin-5 mutations: mechanisms of impaired elastic fiber formation in recessive cutis laxa. Hum Mol Genet 15: 3379-3386.
30. Malek G, Li CM, Guidry C, Medeiros NE, Curcio CA (2003) Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with agerelated maculopathy. Am J Pathol 162: 413-425.
31. Swaroop A, Branham KE, Chen W, Abecasis G (2007) Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits. Hum Mol Genet 16(Spec No. 2): R174-182.
32. Abalain JH, Carre JL, Leglise D, Robinet A, Legall F, et al. (2002) Is age-related macular degeneration associated with serum lipoprotein and lipoparticle levels? Clin Chim Acta 326: 97-104.
33. Nakamura T, Ruiz-Lozano P, Lindner V, Yabe D, Taniwaki M, et al. (1999) DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries. J Biol Chem 274: 22476-22483.
34. Nguyen AD, Itoh S, Jeney V, Yanagisawa H, Fujimoto M, et al. (2004) Fibulin-5 is a novel binding protein for extracellular superoxide dismutase. Circ Res 95: 1067-1074.
35. Vekic J,Kotur-Stevuljevic J, Jelic-Ivanovic Z, Spasic S, Spasojevic-Kalimanovska V, et al. (2007) Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects. Eur J Clin Invest 37: 715-723.
36. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, et al. (2008) Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40: 189-197.